Druck Icon

BEBIG Receives Large Order for Automated Manufacturing Equipment

Berlin, 17.11.2003. BEBIG Isotopen- und Medizintechnik GmbH, a Berlin-based specialist for therapeutic radiation products, has signed a comprehensive equipment delivery deal worth 1.7 mm EUR with an undisclosed, non-European company in the radiation industry. The order represents a second large equipment contract for BEBIG this year, after the sale of a production line for Iodine prostate cancer implants in February. The delivery and the bulk of the income recognition for the new order is expected to occur at the end of the 3rd quarter of 2004. On the first equipment delivery, expected to be income recognized this year, BEBIG successfully completed a validation run a few days ago.

"BEBIG has in the past years already provided medical device and health science companies with specialised equipment for the manufacturing of radioactive components, most notably companies that focussed on vascular brachytherapy", elaborated Dr. André Hess, General Manager in charge of the project. "With the decline of this segment due to the advent of drug coated stents we have shifted our efforts to other isotope manufacturers that can also benefit from BEBIG's extensive and unique automation and radiation experience."

BEBIG Isotopen- und Medizintechnik is a fully owned subsidiary of Berlin based Eckert & Ziegler AG (ISIN 0005659700). It manufactures a range of low-level radioactive products for the treatment of cancer and heart ailments and is the largest European manufacturer of radioactive implants for the treatment of prostate cancer. Further information about these products is available at www.bebig.com.

The Board of Directors